Central Rexall Drugs, Inc Company Profile

10:58 EST 21st November 2017 | BioPortfolio

At Central Rexall Drugs, Inc. we try to do the utmost to treat you the way we like to be treated. Our pharmacists have earned a reputation for professionalism and genuine concern for our customers.
Three generations of the Fellows family have owned and operated Central Rexall Drugs. Central Rexall Drugs has provided more than 107 years of quality service to the Hammond community. Central Rexall Drugs is Hammond's oldest business.

At Central Rexall Drugs, we attribute our success to one main factor, meeting the needs of our patients. We are always available to answer any of your questions.


on the corner of Cypress and Thomas Streets
Downtown Hammond


Email: centraldrugs@

News Articles [757 Associated News Articles listed on BioPortfolio]

Rx Drug Mart receives influx of capital from BDC in its bid for 27 Rexall pharmacies

Michael JohnsenThe $10 million equity investment was used to finance RxDM's acquisition of 27 former Rexall pharmacies from McKesson. read more

Rexall names new president

David SalazarThe new president of Rexall Drugstore brings to the company nearly three decades of experience with Delhaize America and her more recent experience as president of Sobeys’ Atlantic/...

Central Nervous System Drugs Market Global Report 2017 Including: Analgesics, AntiParkinson Drugs, Anaesthetics, AntiEpileptics, Other CNS DrugsCovering: Pfizer Inc., Biogen Idec, Novartis AG, Otsuka, and Teva Pharmaceuticals [Report Updated: 17072017] P

Central nervous system drugs market include medications that are used in the treatment of diseases affecting the brain or spinal cord. The major diseases in the market include bipolar disorders, anxie...

Over 3% of all drugs in Indian market not up to standard

The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that 946 of the medicines across 66 companies failed the test. One of ...

Insights from a rare genetic disease may help treat multiple myeloma

(American Chemical Society) A new class of drugs for blood cancers such as leukemia and multiple myeloma is showing promise. But it is hobbled by a problem that also plagues other cancer drugs: target...

Pharmaceutical Drugs Market Global Report 2017 Including: Cardiovascular Drugs, Dermatological Drugs, Gastrointestinal Drugs, GenitoUrinary Drugs, Hematology Drugs, Drugs For Infectious Diseases, Drugs For Metabolic Disorders, Drugs For Musculoskeletal Di

The market segments in the pharmaceuticals drugs sector as of 2016 were Oncology, Antidiabetics, Antirheumatics, Antivirals, Vaccines, Bronchodilators, Sensory Organs, Antihypertensives, MS Therapies,...

Getting Drugs Past the Blood-Brain Barrier

To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.

New Drugs Approved In October

Yet another month has gone by, and it's time again to take a look-back at the new drugs that successfully crossed the therapeutics finish line. At the time of writing, 37 novel drugs were approved ...

PubMed Articles [1759 Associated PubMed Articles listed on BioPortfolio]

CNS Drug Development: Lessons Learned Part 3: Psychiatric and Central Nervous System Drugs Developed Over the Last Decade-Implications for the Field.

This column reviews the divergence between the approach to drug development in infectious disease, oncology, and immunology versus psychiatry. Between 2009 and 2016, 254 new drugs were approved. Of th...

Prevalence and predictors of potentially inappropriate prescribing of central nervous system and psychotropic drugs among elderly patients: A national population study in Korea.

To investigate the prevalence of potentially inappropriate prescribing (PIP) of central nervous system and psychotropic (CNS-PS) drugs to the Korean elderly population, and to identify PIP-associated ...

Central Aortic Blood Pressure: Important Parameter in Diagnosis and Therapy.

In recent years great emphasis has been placed on the role of central aortic blood pressure as measured non invasively using pulse wave analysis in pathophysiology of cardiovascular diseases and clini...

The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates.

Drugs acting on the cardiovascular and central nervous system often display relatively fast clinical responses, which may differ in neonates compared to children and adults. Introduction of bedside mo...

Characterization of the chloroquine-induced mouse model of pruritus using an automated behavioural system.

Pruritus is a major symptom of several dermatological diseases but has limited therapeutic options available. Animal models replicating the pathophysiology of pruritus are needed to support the develo...

Clinical Trials [2683 Associated Clinical Trials listed on BioPortfolio]

Phenylbutyrate in Treating Children With Progressive or Recurrent Cancer of the Central Nervous System

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of phenylbutyrat...

Direct Measurement of Ideal Depth of Central Line

Total of 89 patients undergoing elective cardiac surgery will be enrolled. Right CVC insertion begins at their intersection of the cricoid cartilage level and the triangular point where t...

Temperature Control in Central Fever in the Neuro-ICU

There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket ...

Effect of the Bevel Direction of Puncture Needle on Success Rate and Complications During Central Venous Catheterization

To test the hypothesis that approaching the internal jugular vein with the needle bevel down would produce less injury to the vessel wall compared to the bevel up approach during central v...

Melphalan With BBBD in Treating Patients With Brain Malignancies

RATIONALE: Drugs used in chemotherapy, such as melphalan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving dr...

Companies [1480 Associated Companies listed on BioPortfolio]

Central Rexall Drugs, Inc

At Central Rexall Drugs, Inc. we try to do the utmost to treat you the way we like to be treated. Our pharmacists have earned a reputation for professionalism and genuine concern for our customers.Th...

Osborn Drugs, Inc.

Osborn Drugs was established in 1971 over 33 years ago. The business was a continuation of the following drug stores beginning in 1895: Alpha Pharmacy, Shirver-Cunningham, Harrah-Obanion, Wiley Rexall...

NBTY, Inc.

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the worl...

Central Drugs

Scion Pharmaceuticals

Scion is focused on identifying and optimizing small-molecule drugs for the treatment of central nervous system (CNS) disorders and cardiovascular diseases. Scion's automated electrophysiology technol...

More Information about "Central Rexall Drugs, Inc" on BioPortfolio

We have published hundreds of Central Rexall Drugs, Inc news stories on BioPortfolio along with dozens of Central Rexall Drugs, Inc Clinical Trials and PubMed Articles about Central Rexall Drugs, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Central Rexall Drugs, Inc Companies in our database. You can also find out about relevant Central Rexall Drugs, Inc Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record